IMRT for prostate cancer: Defining target volume based on correlated pathologic volume of disease

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 1, 2003, Pages 184-191

  Teh, Bin S ^a   Bastasch, Michael D ^a   Wheeler, Thomas M ^a   Mai, Wei Yuan ^a   Frolov, Anna ^b   Uhl, Barry M ^c   Lu, Hsin H ^a   Carpenter, L Steven ^a   Chiu, J Kam ^a   McGary, John ^a   Woo, Shiao Y ^a   Grant III, Walter H ^a   Butler, E Brian ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c X Ray Medical Group   (United States)

Author keywords

CT planning; Extracapsular extension; Gross tumor volume; IMRT; Planning target volume; Prostate cancer; Radiation therapy

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MEDICAL IMAGING; PATIENT MONITORING; TISSUE; TUMORS;

INTENSITY-MODULATED RADIATION THERAPY (IMRT);

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; QUANTITATIVE ANALYSIS; RADIATION DOSE FRACTIONATION; SAFETY; TREATMENT PLANNING;

EID: 0037402943     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00085-3     Document Type: Article

References (48)

1. Teh B.S., Woo S.Y., Butler E.B. Intensity modulated radiation therapy (IMRT) A new promising technology in radiation oncology . Oncologist. 4:1999;433-442.
2. Langen K.M., Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys. 50:2001;265-278.
3. Teh B.S., Greco S.C., Berner B.M., et al. Prostate movement A function of shift and rotation . J Brachytherapy Int. 16:2000;199-206.
4. McGary J.E., Grant W 3rd. A clinical evaluation of setup errors for a prostate immobilization system. J Appl Clin Med Phys. 1:2000;138-147.
5. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization Acute toxicity and dose-volume analysis . Int J Radiat Oncol Biol Phys. 49:2001;705-712.
6. Teh B.S., Mai W.Y., et al. Intensity modulated radiation therapy (IMRT) following prostatectomy More favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer . Int J Radiat Oncol Biol Phys. 49:2001;465-472.
7. McGary J.E., Teh B.S., Butler E.B., et al. Prostate immobilization using a rectal balloon. J Appl Clin Med Phys. 3:2002;6-11.
8. Wheeler T.M., Lebovitz R.M. Fresh tissue harvest for research from prostatectomy specimens. Prostate. 5:1994;274-279.
9. Sohayda C., Kupelian P.A., Levin H.S., et al. Extent of extracapsular extension in localized prostate cancer. Urology. 55:2000;382-386.
10. Greene D.R., Wheeler T.M., Egawa S., et al. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol. 146:1991;1069-1076.
11. Schned A.R., Wheeler K.J., Hodorowski C.A., et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol. 20:1996;1501-1506.
12. Gleason D.F. Histologic grading and clinical staging of prostatic carcinoma. Tannenbaum M. Urologic pathology: the prostate. 1977;171-197 Lea and Febiger, Philadelphia.
13. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300.
14. Hanks G., Lu J., Machtay M., et al. RTOG Protocol 92-02 A phase iii trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate. Proc of Am Soc Ther Radiat Oncol (ASTRO), Boston, MA . Int J Radiat Oncol Biol Phys. 48:2000;112. [Abstract 4].
15. Horwitz E., Winter K., Hanks G., et al. Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term versus short-term adjuvant hormones for patients with locally advanced non-metastatic prostate cancer treated with radiation therapy. Int J Radiat Onco Biol Phys. 9:2001;947-956.
16. Pilepich M., Winter K., Fu K., et al. Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 50:2001;1243-1252.
17. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911.
18. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment five-year outcomes, treatment optimization and future directions. Int J Radiat Oncol Biol Phys. 41:1998;501-510.
19. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
20. Koper P.C.M., Stroom J.C., Van Putten W.L.J., et al. Acute morbidity reduction using 3D-CRT for prostate carcinoma a randomized study . Int J Radiat Oncol Biol Phys. 43:1999;727-734.
21. Hanlon A.L., Schultheiss T.E., Hunt M.A., et al. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 38:1997;59-63.
22. Lee W.R., Hanks G.E., Hanlon A.L., et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer further evidence for a significant dose effect . Int J Radiat Oncol Biol Phys. 35:1996;251-257.
23. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
24. Davis B.J., Pisansky T.M., Wilson T.M., et al. The radial distance of extraprostatic extension of prostate carcinoma Implications for prostate brachytherapy . Cancer. 85:1999;2630-2637.
25. Wheeler T.M., Dillioglugil Ö., Kattan M.W., et al. Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer. Hum Pathol. 29:1998;856-862.
26. McNeal J.E., Redwine E.A., Freiha F.S., et al. Zonal distribution of prostatic adenocarcinoma Correlation with histologic pattern and direction of spread . Am J Surg Pathol. 12:1988;897-906.
27. Chen M.E., Johnston D.A., Tang K., et al. Detailed mapping of prostate carcinoma foci. Biopsy strategy implications, Cancer. 89:2000;1800-1809.
28. Roach M 3rd, Faillace-Akazawa P., Malfatti C., et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 35:1996;1011-1018.
29. D'Amico A.V., Manola J., Marian Loffredo M., et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Bio Phys. 51:2001;1431-1436.
30. Antolak J.A., Rosen I.I., Childress C.H., et al. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 42:1998;661-672.
31. Tinger A., Michalski J.M., Cheng A., et al. A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;213-221.
32. McLaughlin P.W., Wygoda A., Sahijdak W., et al. The effect of patient position and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 45:1999;407-413.
33. Melian E., Mageras G.S., Fuks Z., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys. 38:1997;73-81.
34. Malone S., Donker R., Broader M., et al. Effects of urethrography on prostate position Considerations for radiotherapy treatment planning of prostate carcinoma . Int J Radiat Oncol Biol Phys. 46:2000;89-93.
35. Zelefsky M.J., Crean D., Mageras G.S., et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol. 50:1999;225-234.
36. Rudat V., Schraube P., Oetzel D., et al. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys. 35:1996;1027-1034.
37. Dawson L.A., Litzenberg D.W., Brock K.K., et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys. 48:2000;319-323.
38. Beard C.J., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion Implications for treatment planning . Int J Radiat Oncol Biol Phys. 34:1996;451-458.
39. Padhani A.R., Khoo V.S., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys. 44:1999;525-533.
40. Roeske J.C., Forman J.D., Mesina C.F., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys. 33:1995;1321-1329.
41. Schild S.E., Casale H.E., Bellefontaine L.P. Movements of the prostate due to rectal and bladder distension Implications for radiotherapy . Med Dosim. 18:1993;13-15.
42. Ten Haken R.K., Forman J.D., Heimburger D.K., et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys. 20:1991;1317-1324.
43. van Herk M., Bruce A., Kroes A.P., et al. Quantification of organ motion during conformal radiotherapy of the prostate by three-dimensional image registration. Int J Radiat Oncol Biol Phys. 33:1995;1311-1320.
44. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol. 61:2001;127-133.
45. Gerstner N., Wachter S., Dorner D., et al. Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma. Strahlenther Onkol. 175:2002;232-238.
46. Wachter S., Gerstner N., Dorner D., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 52:2002;91-100.
47. Michalski J.M., Purdy J.A., Harms W.M., et al. 3-D CRT for prostate cancer An update of RTOG94-06 . Purdy J.A., Grant W.H. III, Palta J.R., Butler E.B., Perez C.A. 3-D conformal and IMRT: Physics and clinical applications. 2001;477-482 Advanced Medical Publishing, Madison, WI.
48. Glatstein E. Dr. Strange (high) tech or how I learned to stop worrying, and love my MLC/3D treatment planning, stereotactic linac. Int J Radiat Oncol Biol Phys. 45:1999;1097-1101.